BioSpace News Archive

TScan Therapeutics, Inc. announced it has been named one of the Top Places to Work in Massachusetts in the 15th annual employee-based survey project from The Boston Globe.

Roivant Sciences (Nasdaq: ROIV) and Pfizer Inc. today announced formation of a new Vant to develop and commercialize PF-06480605 (now RVT-3101).

SHL Telemedicine Ltd. today announced that it will be presenting virtually at the upcoming Ladenburg Thalmann Virtual Technology Expo on Wednesday, December 7th, at 9:30 AM ET / 3:30 PM CET.

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved Waylivra™ (volanesorsen) as the first treatment for familial partial lipodystrophy (FPL) in Brazil.

Charles River Laboratories International, Inc. (NYSE: CRL) launches the Endosafe ® Nexus 200™ , expanding its robust endotoxin testing portfolio.

August Bioservices, LLC today announced that it secured $65 million in Series B funding led by Oak HC/FT, who led the Series A in July 2020.

Nemaura Medical, Inc. announces today that CEO Dr. Faz Chowdhury will present a corporate overview at the Planet MicroCap Showcase: Virtual 2022 being held on December 6 – 8, 2022.

Curebase, a company dedicated to democratizing clinical trials through a decentralized model is announcing its partnership with Redenlab, a global leader for speech testing in industry-run clinical trials.

Eisai announced today that new study results on its in-house discovered and developed anticancer agent eribulin mesylate (HALAVEN ® , “eribulin”) will be presented during the 2022 San Antonio Breast Cancer Symposium (SABCS), which is taking place virtually and in-person in San Antonio, Texas from December 6-10.

Surgical Innovation Associates (SIA) today announced that it entered into a definitive agreement to be acquired by Integra LifeSciences Holding Corporation.